THTX: Theratechnologies, Inc Sotuvga nisbatan narx
Theratechnologies Inc. rahbariyati hozirda barqaror daromadlilikka erishish uchun xarajatlarni optimallashtirmoqda. Ushbu narx-savdo ko'rsatkichi grafigi aktivning baholash dinamikasini baholashga yordam beradi, bunda 1.80 ushbu metrikaning so'nggi qiymatini aks ettiradi. Biznes endokrin buzilishlar va OIV ni davolash uchun eksklyuziv dori vositalariga tayanadi. Shimoliy Amerikadagi ishlab chiqarish quvvatlari nisha dori vositalari ishlab chiqarilishini va onkologik terapiyalarning ishlab chiqilishini ta'minlaydi.
Theratechnologies Inc (THTX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Theratechnologies Inc.|THTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Theratechnologies, Inc|THTX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Theratechnologies Inc|THTX - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Theratechnologies|Shoshilinch likvidlik theratech.com
- foyda va bozor koeffitsiyentlari statistikasi:
THTX - Sof foyda|Kelajakdagi foyda Theratechnologies Inc.|THTX - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Theratechnologies, Inc.|THTX - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Theratechnologies Inc|THTX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Theratechnologies|THTX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi theratech.com|THTX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Theratechnologies Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:THTX theratech.com
Uzoq muddatli portfelni shakllantirishda, qadrsiz aktivlarni aniqlash uchun fundamental skriningdan foydalanish juda muhimdir. Ushbu sotuvlarga nisbatan narx koeffitsienti Theratechnologies Inc. (THTX) bozor qiymatini uning yillik savdo hajmi bilan solishtiradi va ushbu grafik tahlili orqali kompaniyaning OIV terapiyasi sohasidagi monopol mavqeini qanchalik samarali monetizatsiya qilayotganini baholash imkonini beradi.
Theratechnologies Inc. kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA: Kapitalizatsiyaning daromadga nisbati|Protagonist Corp - Kapitalizatsiyaning sotish hajmiga nisbati|IMVT: P/S multiplikatori|kiniksa.com - Bozor kapitallashuvining daromadga nisbati|GRFS (Grifols) - P/S multiplikatori|Sotuvga nisbatan narx Adaptive Biotech ADPT|Narxning daromadga nisbati Celldex (CLDX)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|P/S multiplikatori veratx.com VERA|DNTH: Kapitalizatsiyaning daromadga nisbati|Pharvaris NV - Kapitalizatsiyaning sotish hajmiga nisbati|ABCL: P/S multiplikatori|Sotuvga nisbatan narx Tourmaline (TRML)|PGEN (Precigen, Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati pharming.com (PHAR)|P/S multiplikatori NKTR|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|IMNM: Kapitalizatsiya va daromad nisbati|GOSS - Narxning daromadga nisbati|Sotuvga nisbatan narx kalvista.com|Septerna (SEPN) - Narxning daromadga nisbati|PVLA (Pieris Pharma) - Narxning daromadga nisbati|Narxning daromadga nisbati Savara Corp|Sotuvga nisbatan narx Rigel Corp RIGL|P/S multiplikatori ANAB|astriatx.com (ATXS) - Narx/daromad multiplikatori|P/S multiplikatori ENGN (enGene)|Narx/daromad koeffitsiyenti RAPT Therapeutics Inc. (RAPT)|Aerovate - P/S multiplikatori|Sotuvga nisbatan narx Aclaris Therapeutics, Inc|Kyverna Therapeutics (KYTX) - Narxning daromadga nisbati|TLSA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati CABA|VTYX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori AVTX|Narx/daromad koeffitsiyenti Eledon Pharmaceuticals, Inc|Narxning daromadga nisbati Agenus AGEN|CLYM: Kapitalizatsiya va daromad nisbati|Zura Bio - P/S multiplikatori|aTyr Pharma Inc (ATYR) - Kapitalizatsiyaning daromadga nisbati|ADAG (adagene.com) - Kapitalizatsiyaning daromadga nisbati|IMA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati STTK|EQ (Equillium Bio) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori CNTB|IMUX (immunic-therapeutics.com) - Bozor kapitallashuvining daromadga nisbati|Atara Bio - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati IFRX (InflaRx NV)|XFOR: Kapitalizatsiyaning daromadga nisbati|ACET (Adicet Bio) - Kapitalizatsiya va daromad nisbati|celularity.com (CELU) - Narxning daromadga nisbati|Narxning sotuvga nisbati INMB (INmune Bio Inc)|BRNS (Barinthus Bio) - P/S multiplikatori|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|P/S multiplikatori akaritx.com (AKTX)|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|Bozor kapitallashuvining daromadga nisbati QTTB|GOVX - Narxning daromadga nisbati|Edesa Biotech Corp (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|Carisma Therapeutics Inc. (CARM) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati XTLB|BOLT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HCWB|Narx/daromad koeffitsiyenti aptevotherapeutics.com|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI - Narxning daromadga nisbati|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiya va daromad nisbati SCNI (scinai.com)|P/S multiplikatori CALI|AFMD - Sotuvga nisbatan narx|Allakos - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati HOOK (HOOKIPA Pharma, Inc.)|IGM Bio - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ITOS (iteostherapeutics.com)|OCEA: P/S multiplikatori|Sotuvga nisbatan narx TC BioPharm (Holdings) Plc (TCBP)|Narxning daromadga nisbati Third Harmonic Bio, Inc
